New York State Common Retirement Fund’s Cyclerion Therapeutics CYCN Stock Holding History

New York State Common Retirement Fund’s Portfolio CYCN Stock Details CYCN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10	Closed	-$1K	–	3380
2021 Q2	$1K	Sell	10 -594	-98%	-$37.2K	﹤0.01%	3387
2021 Q1	$34K	Sell	604 -6,081	-91%	-$457K	﹤0.01%	3255
2020 Q4	$409K	Sell	6,685 -415	-6%	-$28.3K	﹤0.01%	2444
2020 Q3	$863K	Hold	7,100	–	–	﹤0.01%	1980
2020 Q2	$839K	Buy	7,100 +980	+16%	+$81.9K	﹤0.01%	1958
2020 Q1	$324K	Sell	6,120 -1,170	-16%	-$83.5K	﹤0.01%	2238
2019 Q4	$397K	Hold	7,290	–	–	﹤0.01%	2411
2019 Q3	$1.77M	Hold	7,290	–	–	﹤0.01%	1702
2019 Q2	$1.67M	Buy	+7,290	New	+$2.06M	﹤0.01%	1746

Other funds holding CYCN

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's CYCN Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of Cyclerion Therapeutics (CYCN) in Q3 2021, closing a stake of 10 shares — an estimated $1K sold.

New York State Common Retirement Fund first reported a position in CYCN in Q2 2019 and held it in 9 quarters. The position peaked at $1.77M in Q3 2019. 61 funds tracked by Wall St. Rank hold CYCN as of Q3 2021.

New York State Common Retirement Fund reported no remaining Cyclerion Therapeutics position as of Q3 2021 after selling out during the quarter.
New York State Common Retirement Fund sold 10 Cyclerion Therapeutics shares in Q3 2021, an estimated $1K.
New York State Common Retirement Fund first reported a position in Cyclerion Therapeutics in Q2 2019 and held it in 9 quarters.
New York State Common Retirement Fund's Cyclerion Therapeutics position peaked at $1.77M in Q3 2019.
61 funds tracked by Wall St. Rank held Cyclerion Therapeutics as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.